Pharmacology, Toxicology and Pharmaceutical Science
Antibiotics
100%
Cross-Sectional Study
98%
Antimicrobial Resistance
90%
Diabetes Mellitus
79%
Community Pharmacy
76%
Adverse Event
59%
Infection
56%
Diseases
47%
Antiinfective Agent
45%
Chronic Disease
44%
Drug Interaction
43%
Surgical Infection
41%
Pharmacy Practice
38%
FDA Adverse Event Reporting System
37%
Acinetobacter Baumannii
35%
Side Effect
31%
Escherichia coli
27%
Prevalence
25%
Pharmacotherapy
25%
Drug Resistance
25%
Retrospective Study
23%
Cohort Study
23%
Pseudomonas aeruginosa
22%
Hemoglobin A1c
22%
Klebsiella pneumoniae
22%
Comorbidity
22%
Antibiotic Prophylaxis
20%
4-Aminopyridine
19%
Antithrombocytic Agent
19%
Carcinoembryonic Antigen
19%
Pyroptosis
19%
Surgical Prophylaxis
19%
Inflammation
19%
Adverse Drug Reaction
19%
Hydroxychloroquine
19%
Structure Activity Relationship
19%
Zinc Sulfate
19%
Ceftriaxone
19%
Hospital Pharmacy
19%
COVID-19 Vaccine
19%
Pharmacovigilance
19%
Pharmaceutical Care
19%
Candida
19%
Warfarin
19%
Cefazolin
19%
Staphylococcus Hominis
19%
Polypharmacy
19%
Acinetobacter
19%
Digoxin
19%
Risk Communication
19%
Nursing and Health Professions
Health Care Personnel
63%
Cross-Sectional Study
52%
Telemedicine
47%
Primary Health Care
40%
Health Care Cost
39%
Antimicrobial Resistance
38%
Chronic Disease
30%
Cohort Analysis
28%
Medication Therapy Management
28%
Medication Compliance
23%
Medication Therapy Management Service
23%
Linear Regression Analysis
20%
Diabetes Mellitus
19%
Odds Ratio
19%
Pharmacy Student
19%
Multiple Linear Regression Analysis
19%
Patient Compliance
19%
Confidence Interval
19%
Fibronectin
19%
Cost Effectiveness Analysis
19%
Premature Labor
19%
Pregnancy Outcome
19%
Patient Care
19%
Colistimethate
19%
Perioperative
19%
Surgical Infection
19%
Food and Drug Administration
19%
Fampridine
19%
Household
19%
Health Care Utilization
19%
Antiinfective Agent
18%
Emergency Ward
17%
Carcinoembryonic Antigen
15%
Diseases
13%
Health Care
12%
Asthma
12%
Patient with Diabetes
11%
Health Economics
10%
Healthcare System
9%
Cost Benefit Analysis
9%
Ampicillin
9%
Daptomycin
9%
Artificial Respiration
9%
Hospital Discharge
9%
Consumer Attitude
9%
Socioeconomic Status
7%
Polypharmacy
7%
Multiple Sclerosis
7%
Student T Test
6%
Hospital Pharmacy
6%